Home/Filings/4/0001181431-09-005797
4//SEC Filing

Chelsea Therapeutics International, Ltd. 4

Accession 0001181431-09-005797

CIK 0001333763operating

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:00 PM ET

Size

12.4 KB

Accession

0001181431-09-005797

Insider Transaction Report

Form 4
Period: 2009-01-29
Hewitt L Arthur
Vice Pres. of Drug Development
Transactions
  • Gift

    Common Stock

    2009-01-2958,6830 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $2.62Exp: 2015-01-10Common Stock (68,923 underlying)
    68,923
  • Common Stock

    (indirect: By Spouse)
    58,683
  • Stock Option (Right to Buy)

    Exercise: $1.78Exp: 2019-01-22Common Stock (50,000 underlying)
    50,000
Footnotes (6)
  • [F1]Represents transfer of stock to wife.
  • [F2]Option vests in four equal annual installments beginning on January 22, 2010.
  • [F3]Option vests in four equal annual installments beginning on January 24, 2009.
  • [F4]Option vests in four equal annual installments beginning on February 6, 2008.
  • [F5]Option vests in four equal annual installments beginning on January 19, 2007.
  • [F6]Option vested in two equal annual installments beginning on January 10, 2006.

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333763

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:00 PM ET
Size
12.4 KB